The addition of 1.0 equiv of HBF 4 ·OEt 2 led to a ca. 2−3-fold increase in the catalyst activity of (PCy 3 ) 2 (CO)(Cl)RuH ( 1a ) toward the hydrogenation of alkenes. The stoichiometric reaction of 1a with HBF 4 ·OEt 2 produced a 1:3.5 mixture of the new ruthenium−hydride species 2 and Cy 3 PH + BF 4 - . The catalyst activity of the isolated 2 /Cy 3 PH + mixture was found to be similar to 1a /HBF 4 ·OEt 2 . The complex 2 slowly decomposed in C 6 H 6 solution to give a novel tetrameric complex 3 . The treatment of 1a with HBF 4 ·OEt 2 in CH 3 CN led to the selective formation of the monophosphine species 4, which was converted to the stable complex 5 upon treatment with excess PPh 3 . The reaction of 1a with a weak acid, HSiCl 3, led to the formation of the anionic silyl complex 7 . The structures of 3, 5, and 7 were determined by X-ray crystallography. The formation of η 2 -H 2 complex 8 was observed by NMR at low temperature. These results suggested that the 14-electron species [(PCy 3 )(CO)RuHCl], generated from the selective entrapment of the phosphine ligand, is the key species involved in the catalytic hydrogenation reaction.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: